Newborn screening for hemoglobin blood disorders
Part of Blood & lymphatic clinical trials.
This study will test newborns who may be at higher risk for inherited blood disorders (hemoglobinopathies) using a special screening program called EmoCamp. The goal is to catch these conditions early so babies can get the care they need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be a newborn (just born).
- Your baby must be thought to have a higher chance of having a hemoglobin disorder (like sickle cell disease or thalassemia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens healthy newborns for two inherited blood conditions: sickle cell disease and G6PD deficiency. It is meant to check if these conditions can occur together, which may help doctors provide better care.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This trial offers free genetic screening for rare diseases in newborns. It aims to find health conditions early so babies can get the right care sooner.
This pilot study tries a systematic way to look for several rare “lysosomal storage” diseases in newborns using a specialized lab test on routine blood samples. It may help detect these conditions earlier so treatment can start sooner if needed.
This trial tests a flexible newborn screening process that looks for certain conditions early in life. It may help by catching problems sooner, when treatment can be started earlier.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
Hear when a new SCD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.